Erlotinib antagonizes ABC transporters in acute myeloid leukemia. - Wikidata - wikimedia - TriplyDB

Erlotinib antagonizes ABC transporters in acute myeloid leukemia.

Erlotinib antagonizes ABC transporters in acute myeloid leukemia.

http://www.wikidata.org/entity/Q36426524

about

Trial Watch: Proteasomal inhibitors for anticancer therapy Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Cetuximab enhanced the efficacy of chemotherapeutic agent in ABCB1/P-glycoprotein-overexpressing cancer cells.Immunosurveillance against tetraploidization-induced colon tumorigenesis.Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia Human ABCB1 (P-glycoprotein) and ABCG2 mediate resistance to BI 2536, a potent and selective inhibitor of Polo-like kinase 1 EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells 24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling.Cancer Stem Cells: A Moving Target Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells.Classical and Targeted Anticancer Drugs: An Appraisal of Mechanisms of Multidrug Resistance.Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status.FTY720 enhances chemosensitivity of colon cancer cells to doxorubicin and etoposide via the modulation of P-glycoprotein and multidrug resistance protein 1.Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs.Coexpression of Multiple ABC-Transporters is Strongly Associated with Treatment Response in Childhood Acute Myeloid Leukemia.Erlotinib synergizes with the poly(ADP-ribose) glycohydrolase inhibitor ethacridine in acute myeloid leukemia cells.Trial watch: Tumor-targeting monoclonal antibodies for oncological indications.Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates.Effects of Catechins and Their Related Compounds on Cellular Accumulation and Efflux Transport of Mitoxantrone in Caco-2 Cell Monolayers.Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction.

P2860

Q28082910-AFD61CFD-7B10-4675-ACB8-8D667CEB6F4D Q34103963-C80F50AA-DFA1-4FB6-B682-46D0BD8D9A4D Q36562186-31CCB617-83AC-49DB-ADFC-22B35F860610 Q36654387-41035BDF-F09C-4857-9097-10C36A88FEAF Q37123272-841F5F7B-EAF3-4ABC-AEAA-9BBD73CD176D Q37218015-8D26DBBE-DA7C-4244-B1B6-8ADC42119740 Q37420045-D3CAD3B6-0BC3-40DC-8599-DE98878A15FE Q37728603-9B80AFDF-EFFF-4736-B435-103A58551958 Q38126498-369F184C-CA98-4752-ABEB-51DD58A160F3 Q38618124-79EF3FAD-5E41-48FF-B5B1-236269C363F9 Q38748106-881B2890-DA4F-4123-8C7D-58A1904E0FCB Q38902467-3C809DAA-BFCE-449D-8321-01A7B5CAFBE2 Q38990892-6D3FD449-7134-4915-9C61-F0ABEC215BF8 Q39080596-D2413542-C4E0-425A-A285-3FB6C0A65EC5 Q41172549-C87350CB-6E63-43D9-BAB8-C1A50291AEFA Q42362038-2B811A6C-3EE9-46C4-A636-93CF129EB9CB Q42558833-01C2652E-B504-4D07-BFB1-B6D6D9EE2B40 Q47100454-50820310-B4BF-4D69-9413-174DCF9E2A33 Q51083918-BF437EDE-123C-4618-A49D-56E2E9EF700D Q54239324-B5DE1715-EE4D-4C14-8B65-BBF186362B94

P2860

Erlotinib antagonizes ABC transporters in acute myeloid leukemia.

http://www.wikidata.org/entity/Q36426524

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Erlotinib antagonizes ABC transporters in acute myeloid leukemia.

@ast

Erlotinib antagonizes ABC transporters in acute myeloid leukemia.

@en

type

label

Erlotinib antagonizes ABC transporters in acute myeloid leukemia.

@ast

Erlotinib antagonizes ABC transporters in acute myeloid leukemia.

@en

prefLabel

Erlotinib antagonizes ABC transporters in acute myeloid leukemia.

@ast

Erlotinib antagonizes ABC transporters in acute myeloid leukemia.

@en

P1433

Q36426524-48691EB3-378F-4605-B408-A8879C89EE2F

P1476

Q36426524-51576E4C-21DD-45D4-8812-22C6E0570A93

P2093

Q36426524-1FAABBF6-EE81-4682-ACBE-1CFCD462FDB0

Q36426524-884F34A7-992F-47B6-8F0E-0EDDD1038B48

Q36426524-9DF44051-20B1-4E8B-BBFA-BF37793612A6

Q36426524-BD06CCB2-16C7-4B18-8FAC-336A52815E46

Q36426524-C4CCB935-B37B-4350-9D18-D6DCB86A1A31

Q36426524-E20B5B76-BA1C-4221-BB4D-6A3C282B412C

P2860

Q36426524-02293980-A954-427C-9A3E-3ADFB82ADA03

Q36426524-09069A43-3D15-491A-9EE2-2075BD199FED

Q36426524-0A1C8B37-49C5-4348-8EC6-54BD45C0DB95

Q36426524-0A393918-3138-46A6-9F39-35C34F441F5A

Q36426524-0DA349E5-F554-4F3C-AE6C-9CA1977474FE

Q36426524-165E2FCD-0A03-4B1D-AE6C-BE6A6F050B12

Q36426524-17BF5DB5-27FE-445F-9C7F-EB1F3B00C0A1

Q36426524-1AAD544D-1ADE-450C-9AD5-6FD1A2BBB2FD

Q36426524-1F1D0A98-9810-47BD-8746-6704C9BB55E4

Q36426524-1F606D5D-F24B-4805-A155-452F519AB592

P304

Q36426524-47CA95BA-9017-44DA-8B95-2E96DF4AAC8A

P31

Q36426524-5323F862-B945-452E-ABCC-22A1B9CC745D

P356

Q36426524-F53FDCDE-546E-4EB2-A422-DD50234998EE

P433

Q36426524-0EB3911B-AEDD-4908-85F7-3F517431F501

P478

Q36426524-A4C2C918-750C-4DE5-B8D4-D02AD995BE4B

P50

Q36426524-59B97C50-0545-4D3D-A3CF-98735AE284A4

Q36426524-9EC44AFB-B6E8-492D-80BF-B2AEE86C6B88

Q36426524-EA9BD6DF-AF7E-47E7-88A7-36D0E7F0E4A6

Q36426524-F8EC720D-E222-48F8-ACBA-B90A9D5E4CBA

P577

Q36426524-0DFAE692-9232-4A5A-9AD5-375CE916C919

P5875

Q36426524-A3FE355B-A450-434C-981C-6E6DEDFF04F4

P698

Q36426524-296990A6-7167-438C-835C-528463AB6884

P921

Q36426524-B80AAECA-31B4-437C-BAA5-664D6D64506F

P932

Q36426524-51980389-8BC8-45E1-99E4-172BF82B4036

P356

P1433

P1476

Erlotinib antagonizes ABC transporters in acute myeloid leukemia.

@en

P2093

Carole Leroy

http://www.w3.org/2001/XMLSchema#string

Cyrielle Bouteloup

http://www.w3.org/2001/XMLSchema#string

Elodie Lainey

http://www.w3.org/2001/XMLSchema#string

Marie Scoazec

http://www.w3.org/2001/XMLSchema#string

Marie Sébert

http://www.w3.org/2001/XMLSchema#string

Sylvain Thépot

http://www.w3.org/2001/XMLSchema#string

P2860

Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy

A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia.

CD34- hematopoietic stem cells: current concepts and controversies.

ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?

Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML).

Laminin regulates PI3K basal localization and activation to sustain STAT5 activation.

Analysis of the interaction of induction regimens with p-glycoprotein expression in patients with acute myeloid leukaemia: results from the MRC AML15 trial.

Prognostic impact of high ABC transporter activity in 111 adult acute myeloid leukemia patients with normal cytogenetics when compared to FLT3, NPM1, CEBPA and BAALC

PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism

CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age.

P304

4079-4092

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CC.22382

http://www.w3.org/2001/XMLSchema#string

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Lorenzo Galluzzi

Stéphane de Botton

P577

2012-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232698948

http://www.w3.org/2001/XMLSchema#string

P698

23095522

http://www.w3.org/2001/XMLSchema#string

P921

P932

3507503

http://www.w3.org/2001/XMLSchema#string